ANISEC INJECTION Ireland - English - HPRA (Health Products Regulatory Authority)

anisec injection

chanelle animal health ltd. - ivermectin - solution for injection - 1.0 %w/v - bovine - endectoparasiticides

Anisec 0.5 % w/v Pour-on Solution Ireland - English - HPRA (Health Products Regulatory Authority)

anisec 0.5 % w/v pour-on solution

chanelle pharmaceuticals manufacturing limited - ivermectin - pour-on solution - 0.5 percent weight/volume - ivermectin

ANISEC 0.5 % W/V POUR-ON SOLUTION Ireland - English - HPRA (Health Products Regulatory Authority)

anisec 0.5 % w/v pour-on solution

chanelle animal health ltd. - ivermectin - pour-on solution - 0.5 %w/v - ivermectin - bovine - endectoparasiticides

Anisec 0.5 % w/v Pour-on Solution Ireland - English - HPRA (Health Products Regulatory Authority)

anisec 0.5 % w/v pour-on solution

chanelle animal health ltd. - ivermectin - pour-on solution - 0.5 percent weight/volume - ivermectin - cattle - endectoparasiticides

Granisetron-AFT, granisetron (as hydrochloride) 3 mg/3 mL, concentrated injection, clear type I glass ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

granisetron-aft, granisetron (as hydrochloride) 3 mg/3 ml, concentrated injection, clear type i glass ampoule

aft pharmaceuticals pty ltd - granisetron hydrochloride, quantity: 3.36 mg (equivalent: granisetron, qty 3 mg) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; nitrogen; citric acid monohydrate; sodium citrate dihydrate - granisetron injection is indicated in:,adults: - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy - for the prevention of nausea and vomiting induced by radiotherapy,children: - for the prevention of nausea and vomiting induced by cytotoxic chemotherapy

Granisetron-AFT, granisetron (as hydrochloride) 1 mg/mL, concentrated injection, clear type I glass ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

granisetron-aft, granisetron (as hydrochloride) 1 mg/ml, concentrated injection, clear type i glass ampoule

aft pharmaceuticals pty ltd - granisetron hydrochloride, quantity: 1.12 mg (equivalent: granisetron, qty 1 mg) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; nitrogen; sodium citrate dihydrate; citric acid monohydrate - granisetron injection is indicated in:,adults: - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy - for the prevention of nausea and vomiting induced by radiotherapy,children: - for the prevention of nausea and vomiting induced by cytotoxic chemotherapy

APO-GRANISETRON granisetron hydrochloride 1mg/1mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

apo-granisetron granisetron hydrochloride 1mg/1ml injection ampoule

arrotex pharmaceuticals pty ltd - granisetron hydrochloride, quantity: 1.12 mg (equivalent: granisetron, qty 1 mg) - injection - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; citric acid monohydrate - adults: granisetron injection is indicated for use in adults for:,the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy;,the prevention of nausea and vomiting induced by radiotherapy.,granisetron injection is also indicated for use in the prevention and treatment of post-operative nausea and vomiting.,children: granisetron injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

APO-GRANISETRON granisetron hydrochloride 3mg/3mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

apo-granisetron granisetron hydrochloride 3mg/3ml injection ampoule

arrotex pharmaceuticals pty ltd - granisetron hydrochloride, quantity: 3.36 mg (equivalent: granisetron, qty 3 mg) - injection - excipient ingredients: citric acid monohydrate; hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - adults: granisetron injection is indicated for use in adults for:,the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy;,the prevention of nausea and vomiting induced by radiotherapy.,granisetron injection is also indicated for use in the prevention and treatment of post-operative nausea and vomiting.,children: granisetron injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

GRANISETRON KABI granisetron (as hydrochloride) 3mg/3mL concentrated injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

granisetron kabi granisetron (as hydrochloride) 3mg/3ml concentrated injection ampoule

fresenius kabi australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; citric acid monohydrate; sodium chloride - prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults and children. prevention of nausea and vomiting induced by radiotherapy in adults only. prevention and treatment of post-operative nausea and vomiting in adults only.

GRANISETRON KABI granisetron (as hydrochloride) 1mg/1mL concentrated injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

granisetron kabi granisetron (as hydrochloride) 1mg/1ml concentrated injection ampoule

fresenius kabi australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, concentrated - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; citric acid monohydrate; water for injections - prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults and children. prevention of nausea and vomiting induced by radiotherapy in adults only. prevention and treatment of post-operative nausea and vomiting in adults only.